Kao Corp. Aktie
17,82 €
Deine Einschätzung
Kao Corp. Aktie
Was spricht für und gegen Kao Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Kao Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Kao Corp. | 0,73 % | -50,00 % | -45,19 % | -52,53 % | -48,00 % | -47,04 % | -66,70 % |
| Unicharm Corp. | -3,69 % | -1,39 % | -2,35 % | - | 2,47 % | - | - |
| Pola Orbis Holdings Inc. | 1,46 % | 2,96 % | 4,51 % | -5,44 % | 0,00 % | -46,95 % | -68,41 % |
| Kose Corp | 4,29 % | 7,35 % | 2,82 % | -14,62 % | 4,29 % | -67,56 % | -78,05 % |
Kommentare
News
Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders
On May 11, 2026, John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 298,000 shares of common stock for a total transaction value of
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Know
John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 118,000 shares for a transaction value of about $2.06 million, according to a SEC Form 4





